Generalized vitiligo in a psoriatic patient treated with ixekizumab

Dermatol Ther. 2022 Dec;35(12):e15872. doi: 10.1111/dth.15872. Epub 2022 Oct 17.

Authors

Pirunthan Pathmarajah¹, Zara Benjamin-Laing¹, Maryam Abdurrahman¹, Antoaneta Grunova¹, Catriona Sinclair¹

Affiliation

¹ Department of Dermatology, Broomfield Hospital, Mid and South Essex NHS Trust, Broomfield, UK.

PMID: 36181252
DOI: 10.1111/dth.15872

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Arthritis, Psoriatic*
Humans
Treatment Outcome
Vitiligo* / chemically induced
Vitiligo* / diagnosis

Substances

ixekizumab
Antibodies, Monoclonal, Humanized